Pancreatic cancer is considered rare, with an estimated 67,440 new cases diagnosed in the U.S. in 2024. Even so, it is the third-leading cause of cancer-related death in the U.S.
You’re about to leave the Nebraska Medicine website. The other site may collect information about your visit, including your IP address. Do you want to continue?